Annexon, Inc. Files 8-K Report
Ticker: ANNX · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1528115
Sentiment: neutral
Topics: regulatory-filing, financial-statements
TL;DR
Annexon filed an 8-K, mostly just paperwork, no big news.
AI Summary
On January 13, 2025, Annexon, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text.
Why It Matters
This filing indicates Annexon, Inc. is meeting its regulatory reporting requirements, though it does not disclose new material information.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not contain information that would immediately impact the company's risk profile.
Key Players & Entities
- Annexon, Inc. (company) — Registrant
- January 13, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39402 (identifier) — Commission File Number
- 27-5414423 (identifier) — IRS Employer Identification No.
- 1400 Sierra Point Parkway, Bldg C, Suite 200 Brisbane, California 94005 (address) — Address of principal executive offices
- (650) 822-5500 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Annexon, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of January 13, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on January 13, 2025.
What is Annexon, Inc.'s state of incorporation?
Annexon, Inc. is incorporated in Delaware.
What is Annexon, Inc.'s principal executive office address?
Annexon, Inc.'s principal executive office is located at 1400 Sierra Point Parkway, Bldg C, Suite 200, Brisbane, California 94005.
Does this filing disclose any new material business developments for Annexon, Inc.?
Based on the provided text, this filing primarily concerns routine reporting of financial statements and exhibits, and does not explicitly detail new material business developments.
Filing Stats: 474 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-13 08:06:03
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share ANNX The Nasdaq Stock Mar
Filing Documents
- d38866d8k.htm (8-K) — 24KB
- d38866dex991.htm (EX-99.1) — 20KB
- g38866g89h63.jpg (GRAPHIC) — 4KB
- 0001193125-25-005009.txt ( ) — 178KB
- annx-20250113.xsd (EX-101.SCH) — 3KB
- annx-20250113_lab.xml (EX-101.LAB) — 18KB
- annx-20250113_pre.xml (EX-101.PRE) — 11KB
- d38866d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated January 13, 2025, titled "Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year." 104 Cover Page Interactive Data File, formatted in inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 13, 2025 Annexon, Inc. By: /s/ Jennifer Lew Jennifer Lew Executive Vice President and Chief Financial Officer